← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Protein Metrics, Llc
Cupertino, CA
$9,127,658
Total funding
14
Grants
Funding over time
peak $1.7M · FY2012–22$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,127,658 · 14
By mechanism
R42$3,163,822 · 3
R44$2,560,939 · 2
R41$2,063,298 · 5
R43$939,474 · 3
R21$400,125 · 1
Investigators at Protein Metrics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes$799,604
R44 · FY2021 · GM
New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes$795,816
R44 · FY2022 · GM
Integrated Platform for Mass-Spectrometric Studies of Protein Structure$614,214
R42 · FY2021 · GM
Integrated Platform for Mass-Spectrometric Studies of Protein Structure$613,930
R42 · FY2020 · GM
Protein Sequencing Tools for Biological Therapeutics$494,418
R42 · FY2016 · GM
Protein Sequencing Tools for Biological Therapeutics$494,418
R42 · FY2015 · GM
Byologic: Software for Mass Spectrometric Protein Drug Assays$484,031
R44 · FY2015 · GM
Byologic: Software for Mass Spectrometric Protein Drug Assays$481,488
R44 · FY2016 · GM
Advancing Protein Identification for Imaging Mass Spectrometry for Pathology$348,649
R43 · FY2012 · GM
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers$342,930
R41 · FY2014 · GM
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers$342,930
R41 · FY2015 · GM
Protein Sequencing Tools for Biological Therapeutics$336,885
R41 · FY2012 · GM
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers$315,614
R42 · FY2018 · GM
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers$315,614
R42 · FY2019 · GM
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers$315,614
R42 · FY2017 · GM
Multistage LC-MSn for automated glycan isomer assignment of glycopeptides$256,570
R41 · FY2021 · GM
Protein Sequencing Tools for Biological Therapeutics$240,092
R41 · FY2013 · GM
New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes$225,000
R43 · FY2019 · GM
Integrated tools for higher order structure determination by cross-link analysis$224,870
R41 · FY2017 · GM
Integrated Platform for Mass Spectrometric Studies of Protein Structure$210,175
R41 · FY2017 · GM